A detailed history of Keybank National Association transactions in Abbott Laboratories stock. As of the latest transaction made, Keybank National Association holds 1,011,363 shares of ABT stock, worth $105 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
1,011,363
Previous 1,044,213 3.15%
Holding current value
$105 Million
Previous $115 Million 0.01%
% of portfolio
0.48%
Previous 0.52%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $3.6 Million - $3.97 Million
-32,850 Reduced 3.15%
1,011,363 $115 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $2.14 Million - $2.62 Million
-23,689 Reduced 2.22%
1,044,213 $115 Million
Q3 2023

Nov 08, 2023

SELL
$95.53 - $114.62 $1.79 Million - $2.15 Million
-18,716 Reduced 1.72%
1,067,902 $103 Million
Q2 2023

Aug 01, 2023

SELL
$100.78 - $112.29 $297,603 - $331,592
-2,953 Reduced 0.27%
1,086,618 $118 Million
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $951,649 - $1.12 Million
-9,825 Reduced 0.89%
1,089,571 $110 Million
Q4 2022

Jan 31, 2023

SELL
$95.06 - $111.52 $748,882 - $878,554
-7,878 Reduced 0.71%
1,099,396 $121 Million
Q3 2022

Oct 27, 2022

SELL
$96.76 - $112.03 $1.4 Million - $1.62 Million
-14,450 Reduced 1.29%
1,107,274 $107 Million
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $2.37 Million - $2.87 Million
-23,264 Reduced 2.03%
1,121,724 $122 Million
Q1 2022

Apr 28, 2022

SELL
$114.02 - $139.04 $1.81 Million - $2.21 Million
-15,875 Reduced 1.37%
1,144,988 $136 Million
Q4 2021

Feb 07, 2022

SELL
$115.53 - $141.46 $1.66 Million - $2.03 Million
-14,338 Reduced 1.22%
1,160,863 $163 Million
Q3 2021

Nov 08, 2021

SELL
$116.66 - $129.06 $204,038 - $225,725
-1,749 Reduced 0.15%
1,175,201 $139 Million
Q2 2021

Aug 12, 2021

SELL
$105.79 - $124.53 $2.78 Million - $3.27 Million
-26,274 Reduced 2.18%
1,176,950 $136 Million
Q1 2021

May 07, 2021

SELL
$108.84 - $128.23 $2.8 Million - $3.29 Million
-25,685 Reduced 2.09%
1,203,224 $144 Million
Q4 2020

Feb 09, 2021

SELL
$105.0 - $114.42 $3.13 Million - $3.41 Million
-29,806 Reduced 2.37%
1,228,909 $135 Million
Q3 2020

Oct 29, 2020

SELL
$91.64 - $111.29 $1.66 Million - $2.01 Million
-18,100 Reduced 1.42%
1,258,715 $137 Million
Q2 2020

Aug 10, 2020

SELL
$76.57 - $98.0 $2.29 Million - $2.93 Million
-29,935 Reduced 2.29%
1,276,815 $117 Million
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $4.75 Million - $6.94 Million
-75,563 Reduced 5.47%
1,306,750 $103 Million
Q4 2019

Feb 05, 2020

SELL
$78.51 - $87.4 $11.2 Million - $12.5 Million
-143,245 Reduced 9.39%
1,382,313 $120 Million
Q3 2019

Nov 04, 2019

SELL
$81.84 - $88.74 $2.43 Million - $2.64 Million
-29,728 Reduced 1.91%
1,525,558 $128 Million
Q2 2019

Aug 01, 2019

BUY
$72.88 - $85.0 $617,658 - $720,375
8,475 Added 0.55%
1,555,286 $131 Million
Q1 2019

May 08, 2019

BUY
$66.22 - $80.06 $2.32 Million - $2.81 Million
35,056 Added 2.32%
1,546,811 $124 Million
Q4 2018

Jan 30, 2019

BUY
$65.56 - $74.27 $16,717 - $18,938
255 Added 0.02%
1,511,755 $109 Million
Q3 2018

Nov 08, 2018

BUY
$60.81 - $73.36 $1.1 Million - $1.33 Million
18,107 Added 1.21%
1,511,500 $111 Million
Q2 2018

Aug 08, 2018

BUY
$57.57 - $63.54 $3.73 Million - $4.11 Million
64,713 Added 4.53%
1,493,393 $91.1 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $8.69 Million - $9.83 Million
154,452 Added 12.12%
1,428,680 $85.6 Million
Q4 2017

Feb 08, 2018

BUY
$53.68 - $57.47 $1.77 Million - $1.9 Million
32,987 Added 2.66%
1,274,228 $72.7 Million
Q3 2017

Nov 02, 2017

BUY
$48.06 - $53.64 $1.38 Million - $1.54 Million
28,662 Added 2.36%
1,241,241 $66.2 Million
Q2 2017

May 14, 2018

SELL
N/A
-10,844 Reduced 0.89%
1,212,579 $58.9 Million
Q1 2017

May 14, 2018

SELL
N/A
-4,773 Reduced 0.39%
1,223,423 $54.3 Million
Q4 2016

May 14, 2018

BUY
N/A
1,228,196
1,228,196 $47.2 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.